High-dose misoprostol used in outpatient management of first trimester spontaneous abortion

S Sifakis, E Angelakis, E Vardaki, Y Fragouli… - Archives of gynecology …, 2005 - Springer
Aim The aim of this study was to evaluate the efficacy and tolerance of a high dose of
vaginal misoprostol for outpatient medical management of missed abortion. Methods Three …

Home self-administration of vaginal misoprostol for medical abortion at 50–63 days compared with gestation of below 50 days

H Kopp Kallner, C Fiala, O Stephansson… - Human …, 2010 - academic.oup.com
BACKGROUND Home use of misoprostol for termination of pregnancy is still controversial in
many countries. Acceptability of home use of misoprostol has been investigated in …

First-trimester pregnancy termination with 800 μg of vaginal misoprostol every 12 h

N Salakos, A Kountouris, D Botsis, D Rizos… - … European Journal of …, 2005 - Taylor & Francis
The objective of the study was to evaluate the efficacy and safety of 800 μg of misoprostol
every 12 h, for a period of 36 h for pharmacological abortion. A group of 162 volunteer …

[HTML][HTML] Comparison between sublingual and vaginal route of misoprostol in management of first trimester miscarriage missing

Z Dehbashi, M Moosazadeh, M Afshari - Materia socio-medica, 2016 - ncbi.nlm.nih.gov
Background: Each year, more than forty million abortions are occurred whole of the world.
Misoprostol is a prostaglandin analogue with a strong uterotonic effect. The present study …

Vaginal misoprostol 1000 μg for early abortion

JLL Carbonell, J Rodriguez, S Aragon, A Velazco… - Contraception, 2001 - Elsevier
The objective of this study was to evaluate the safety and efficacy of 1000 μg misoprostol
vaginally (Cytotec) self-administered into the vagina for medical abortion. Three-hundred …

Association between gestational age and induction-to-abortion interval in mid-trimester pregnancy termination using misoprostol

D Vitner, M Deutsch, Y Paz, N Khatib, T Baltiter… - European Journal of …, 2011 - Elsevier
OBJECTIVE: The study was aimed to evaluate the effectiveness, outcome, and pain intensity
of the vaginal administration of misoprostol for the induction of abortion between 13 and 24 …

Medical abortion from 12 through 14 weeks' gestation: a retrospective study with 126 patients

V Lavoue, L Vandenbroucke, A Grouin… - … et Biologie de la …, 2011 - europepmc.org
Objective To assess the efficacy of medical abortion performed according to a single
protocol from 12 through 14 weeks. Study design Retrospective observational study of …

Expanding a woman's options to include home use of misoprostol for medical abortion up until 76 days: an observational study of efficacy and safety

A Larsson, AKM Ronnberg - Acta Obstetricia et Gynecologica …, 2019 - Wiley Online Library
Introduction Home use of misoprostol for medical abortion is increasingly being practiced.
With gestational length up to 70 days, it is considered effective, safe and acceptable by …

Sublingual vs vaginal misoprostol for completion of first trimester missed abortion: A randomised controlled trial

A Abdelshafy, H Awwad, A Abo-Gamra… - … European Journal of …, 2019 - Taylor & Francis
Objective: The study aimed to compare the efficacy and safety of sublingual and vaginal
misoprostol for termination of pregnancy in women with first trimester missed abortion …

[HTML][HTML] A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days' LMP: a prospective comparative open-label …

H Bracken, R Dabash, G Tsertsvadze, S Posohova… - Contraception, 2014 - Elsevier
Objective To test the effectiveness and acceptability of an outpatient medical abortion
protocol with 200 mg mifepristone and 400 mcg sublingual misoprostol at 64–70 days' last …